Trademark: 79284012
Word
TRB
Status
Registered
Status Code
700
Status Date
Tuesday, February 2, 2021
Serial Number
79284012
Registration Number
6258760
Registration Date
Tuesday, February 2, 2021
Mark Type
3000
Filing Date
Wednesday, March 11, 2020
Published for Opposition
Tuesday, November 17, 2020

Trademark Owner History
TRB CHEMEDICA INTERNATIONAL SA - Original Registrant

Classifications
5 pharmaceuticals, namely, anti-neurodegenerative, anti-neurotrophic, anti-antineurotoxic, neuroprotective and neurorestorative effect agents; pharmaceuticals, namely, immunopharmaceuticals; medical and veterinary preparations, namely, preparations for use in treating joint disease in horses, and antioxidants; pharmaceutical and medicinal preparations and substances for treating and preventing ophthalmic, ocular, neurological, metabolic, dermatological, arthritic, cognitive, or sexual dysfunction-related conditions, disorders or diseases; pharmaceutical and medicinal preparations and substances for treating and preventing joint, ligament, tendon, cartilage, bone, damaged skin or tissue-related conditions, disorders or diseases; pharmaceutical and medicinal preparations and substances for the treatment of central or peripheral nervous system-related, spinal cord-related, or early stages of traumatic or acute vascular injury-related disorders and diseases; pharmaceutical and medicinal preparations and substances for the treatment of pain, inflammation, physical lesions, and wounds; analgesics; anti-inflammatories; medicines for the treatment of keratitis, Sjögren's syndrome or primary dry eye syndrome; medicines for use as surgical aid during cataract surgery procedures; medicines for the treatment of osteoarthritis and rheumatoid arthritis; medicines for the prevention of osteoporosis; medicines for the treatment of musculo-skeletal conditions, disorders or diseases; medicines for the treatment of tendinopathy; medicines for joint recovery after arthroscopy; medicines to help assist with the regeneration of ligament and tendon fibers; medicines for the treatment of immune system related diseases and disorders; medicines for the treatment of blepharitis, glaucoma, and degenerative eye pathologies; pharmaceutical drugs for the treatment of keratitis, Sjögren's syndrome or primary dry eye syndrome; pharmaceutical drugs for use as surgical aid during cataract surgery procedures; pharmaceutical drugs for the treatment of osteoarthritis and rheumatoid arthritis; pharmaceutical drugs for the prevention of osteoporosis; pharmaceutical drugs for the treatment of musculo-skeletal conditions, disorders or diseases; pharmaceutical drugs for the treatment of tendinopathy; pharmaceutical drugs for joint recovery after arthroscopy; pharmaceutical drugs to help assist with the regeneration of ligament and tendon fibers; pharmaceutical drugs for the treatment of immune system related diseases and disorders; pharmaceutical drugs for the treatment of blepharitis, glaucoma, and degenerative eye pathologies; therapeutic drugs for the treatment of keratitis, Sjögren's syndrome or primary dry eye syndrome; therapeutic drugs for use as surgical aid during cataract surgery procedures; therapeutic drugs for the treatment of osteoarthritis and rheumatoid arthritis; therapeutic drugs for the prevention of osteoporosis; therapeutic drugs for the treatment of musculo-skeletal conditions, disorders or diseases; therapeutic drugs for the treatment of tendinopathy; therapeutic drugs for joint recovery after arthroscopy; therapeutic drugs to help assist with the regeneration of ligament and tendon fibers; therapeutic drugs for the treatment of immune system related diseases and disorders, and therapeutic agents for the treatment of keratitis, Sjögren's syndrome or primary dry eye syndrome; therapeutic agents for use as surgical aid during cataract surgery procedures; therapeutic agents for the treatment of osteoarthritis and rheumatoid arthritis; therapeutic agents for the prevention of osteoporosis; therapeutic agents for the treatment of musculo-skeletal conditions, disorders or diseases; therapeutic agents for the treatment of tendinopathy; therapeutic agents for joint recovery after arthroscopy; therapeutic agents to help assist with the regeneration of ligament and tendon fibers; therapeutic agents for the treatment of immune system related diseases and disorders; transdermal patches featuring vitamins for increasing energy for medical use; biological cartilage, bone or skin tissue intended for subsequent implantation; biological preparations for medical or veterinary use, namely, for the treatment of infectious diseases; sanitary preparations for medical purposes; dietetic food and substances in the nature of food supplements and vitamins supplements all adapted for medical or veterinary use; food for babies; dietary supplements for humans and animals; meal replacements, namely, meal replacement bars adapted for medical use and meal replacement beverages adapted for medical use, and dietetic beverages adapted for medical and veterinary use; materials for dressings, namely, dressings for wounds, burns or surgery, adhesive bandages, gauze for dressings, pledgets; disinfectants
The mark consists of a circular design outlined in blue containing zig-zag bands in blue followed to the right by the letters "TRB" in blue. The color white represents background, outlining, shading, and/or transparent areas and is not part of the mark.
The color(s) blue is/are claimed as a feature of the mark.

Trademark Events
Feb 26, 2023
Teas Change Of Correspondence Received
Feb 26, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 26, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 30, 2021
Final Decision Transaction Processed By Ib
May 18, 2021
Teas Change Of Correspondence Received
May 18, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
May 18, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 5, 2021
Final Disposition Notice Sent To Ib
May 5, 2021
Final Disposition Processed
May 2, 2021
Final Disposition Notice Created, To Be Sent To Ib
Feb 2, 2021
Registered-Principal Register
Nov 17, 2020
Official Gazette Publication Confirmation E-Mailed
Nov 17, 2020
Published For Opposition
Oct 28, 2020
Notification Of Notice Of Publication E-Mailed
Oct 13, 2020
Approved For Pub - Principal Register
Oct 8, 2020
Teas/Email Correspondence Entered
Oct 7, 2020
Correspondence Received In Law Office
Oct 7, 2020
Teas Response To Office Action Received
Jul 18, 2020
Refusal Processed By Ib
Jun 30, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Jun 30, 2020
Refusal Processed By Mpu
May 29, 2020
Non-Final Action (Ib Refusal) Prepared For Review
May 28, 2020
Non-Final Action Written
May 21, 2020
Assigned To Examiner
May 1, 2020
Application Filing Receipt Mailed
Apr 27, 2020
New Application Office Supplied Data Entered
Apr 23, 2020
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24